balixafortide [1179]
balixafortide
| SMILES | CC1NNC(Cc2c[nH]cn2)C(=O)NC(Cc2ccc(O)cc2)C(=O)N2CCCC2C(=O)N2CCCC2C(=O)NC(CCCCN)C(=O)NC(CCC(N)=O)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC2CSSCC(NC1=O)C(=O)NC(CO)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CCN)C(=O)NC(CCCNC(=N)N)C(=O)C(=O)C(Cc1ccc(O)cc1)NC2=O |
| InChIKey | OYWQJZAVFWOOBF-UHFFFAOYSA-N |
| Sequence | None |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
balixafortide
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|